MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3

Cellular Physiology and Biochemistry

Volumn 35, Issue 1, 2015, Pages 71-82

  Deng, Xianzhao ^a   Wu, Bo ^a   Xiao, Ke ^b,c   Kang, Jie ^a   Xie, Jing ^a   Zhang, Xiaoping ^b,c   Fan, Youben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Metastasis; MiR 146b 5p; Thyroid cancer; ZNRF3

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 146B 5P; NERVE CELL ADHESION MOLECULE; RING FINGER PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 6; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; WNT PROTEIN; ZINC FINGER PROTEIN; ZINC RING FINGER 3 PROTEIN; 3' UNTRANSLATED REGION; ANTISENSE OLIGONUCLEOTIDE; FZD6 PROTEIN, HUMAN; LRP6 PROTEIN, HUMAN; MIRN146 MICRORNA, HUMAN; UBIQUITIN PROTEIN LIGASE; ZINC AND RING FINGER 3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING SITE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MULTIGENE FAMILY; PAPILLARY THYROID CARCINOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROID CARCINOMA; TUMOR INVASION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHEMISTRY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEQUENCE ALIGNMENT; THYROID TUMOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADULT; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FRIZZLED RECEPTORS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDES, ANTISENSE; SEQUENCE ALIGNMENT; THYROID NEOPLASMS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84920771093     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369676     Document Type: Article

References (25)

1. Rebecca S, Deepa N, Ahmedin J: CA: A Cancer J Clinicians 2012; Cancer statistics 2012;62:10-29.
2. Gonzalez-Gonzalez R, Bologna-Molina R, Carreon-Burciaga RG, Gmezpalacio-Gastelum M, Molina-Frechero N, Salazar-Rodrguez S: Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature. ISRN Oncol 2011;2011:915925.
3. Lv M, Zhang X, Li M, Chen Q, Ye M, Liang W, Ding L, Cai H, Fu D, Lv Z: miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma. PLoS ONE 2013;8:e67591.
4. Wang D, Qiu C, Zhang H, Wang J, Cui Q, Yin Y: Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS ONE 2010;5: pii: e13067. doi: 10.1371/journal.pone.0013067.
5. Chou CK, Chen RF, Chou FF, Chang HW, Chen YJ, Lee YF, Yang KD, Cheng JT, Huang CC, Liu RT: miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid 2010;20:489-494.
6. Pallante P, Visone R, Croce CM, Fusco A: Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 2010;17:F91-104.
7. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005;102:19075-19080.
8. Chou CK, Yang KD, Chou FF, Huang CC, Lan YW, Lee YF, Kang HY, Liu RT: Prognostic Implications of miR- 146b Expression and Its Functional Role in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 2013;98: 196-E205.
9. Geraldo MV, Yamashita AS, Kimura ET: MicroRNA miR-146b-5p regulates signal transduction of TGF-[beta] by repressing SMAD4 in thyroid cancer. Oncogene 2012;31:1910-1922.
10. Christofori G: New signals from the invasive front. Nature 2006;441:444-450.
11. Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-Mesenchymal Transitions in Development and Disease. Cell 2009;139:871-890.
12. Yang J, Weinberg RA: WEINBERG. Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis. Dev Cell 2008;14:818-829.
13. Zhang X, Li M, Zuo K, Li D, Ye M, Ding L, Cai H, Fu D, Fan Y, Lv Z: Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/β-Catenin Signaling. J Clin Endocrinol Metab 2013;98:E1305-E1313.
14. Livak KJ, Schmittgen TD: Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T))Method. Methods 2001;25:402-408.
15. Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H, Mao X, Ma Q, Zamponi R, Bouwmeester T, Finan PM, Kirschner MW,Porter JA, Serluca FC, Cong F: ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 2012;485:195-200.
16. Peng WC, de Lau W, Madoori PK, Forneris F, Granneman JC, Clevers H, Gros P: Structures of Wnt-Antagonist ZNRF3 and Its Complex with R-Spondin 1 and Implications for Signaling. PLoS ONE 2013;8:e83110.
17. Cadigan KM, Nusse R: Wnt signaling: a common theme in animal development. Genes & Development 1997;11:3286-3305.
18. Helmbrecht K, Kispert A, von Wasielewski R, Brabant G: Identification of a Wnt/β-Catenin Signaling Pathway in Human Thyroid Cells. Endocrinology 2001;142:5261-5266.
19. Sastre-Perona A, Santisteban P: Role of the Wnt pathway in thyroid cancer. Front Endocrinol 2012;3:31. doi: 10.3389/fendo.2012.00031. eCollection 2012.
20. Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG, Weiss SJ: Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA 2012;109:16654-16659.
21. Snchez-Till E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, Postigo A: EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012;69:3429-3456.
22. Xu J, Lamouille S, Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009;19:156-72.
23. Zhou Y, Lan J, Wang W, Shi Q, Lan Y, Cheng Z, Guan H: ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma. J Mol Histol. 2013;44:555-563.
24. Jiang X, Hao HX, Growney JD, Woolfenden S, Bottiglio C, Ng N, Lu B, Hsieh MH, Bagdasarian L, Meyer R, Smith TR, Avello M, Charlat O, Xie Y, Porter JA, Pan S, Liu J, McLaughlin ME, Cong F: Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA 2013;110:12649-12654.
25. Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE, Bowtell DD: Australian Ovarian Cancer Study Group, Gorringe KL, Campbell IG: RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol 2013;229:469-476.